HIV 1 News and Research

RSS

International community must keep fighting to end mother-to-child HIV transmission

"Even with the knowledge and medicines to prevent transmission of HIV from mothers to children, there are still babies being born with HIV in the U.S. and around the world," Jake Glaser, Janice McCall, and Cristina Pena -- all persons living with HIV who contracted the virus through mother-to-child transmission and who work as ambassadors for the Elizabeth Glaser Pediatric AIDS Foundation -- write in the Huffington Post's "Global Motherhood" blog.

18 Dec 2012

IRMA, Population Council and MTN release Rectal Revolution video project

International Rectal Microbicide Advocates (IRMA), the Population Council, and the Microbicide Trials Network (MTN) today released a collaborative video project called "The Rectal Revolution Is Here: An Introduction to Rectal Microbicide Clinical Trials." The jointly produced video, the first of its kind, is designed to educate communities affected by HIV about rectal microbicide development and the importance of participating in clinical trials to help speed the search for new HIV prevention options.

18 Dec 2012

Increased life expectancy not benefitting everybody equally: U of T

Global lifespans have risen dramatically in the past 40 years, but the increased life expectancy is not benefitting everybody equally, say University of Toronto researchers. In particular, adult males from low- and middle-income countries are losing ground.

17 Dec 2012

PlusNews reviews AVAC priorities for 2013 HIV prevention agenda

"If the world scales-up HIV treatment and prevention in the next two years, a critical tipping point -- in which those on treatment outnumber those newly infected with the virus -- could be reached, according to the global HIV prevention advocacy organization AVAC," PlusNews reports.

15 Dec 2012

Though progress made, global burden of HIV/AIDS requires greater, 'better' response

"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.

15 Dec 2012

Examining developing country contributions to AIDS response

"World AIDS Day 2012 offered numerous personal stories in the global fight against HIV and AIDS, but perhaps the most intriguing story, however, was a policy one: How developing countries are making significant contributions to the fight against AIDS in their own countries,"

15 Dec 2012

WHO releases new guidelines for interventions aimed at protecting sex workers from HIV

The WHO on Wednesday "released new guidelines providing technical recommendations on effective interventions for the prevention and treatment of HIV and other sexually transmitted infections (STIs) among sex workers and their clients," New Europe Online reports.

15 Dec 2012

Study suggests that existing HIV drug could be a potential therapy for Staph infections

A new study by NYU School of Medicine researchers suggests that an existing HIV drug called maraviroc could be a potential therapy for Staphylococcus aureus, a notorious and deadly pathogen linked to hundreds of thousands of hospitalizations each year.

15 Dec 2012

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

Malaria is an infection caused by a parasite called plasmodium, which is transmitted from person to person by females of some species of mosquito. It is primarily a disease of tropical countries.

14 Dec 2012

IRIN examines HIV/AIDS response in Guinea-Bissau

IRIN reports on the HIV/AIDS response in Guinea-Bissau, writing, "One year after the Global Fund to Fight AIDS, Tuberculosis and Malaria reduced funding to the Guinea-Bissau government body in charge of coordinating HIV prevention and treatment activities, health centers outside the capital are facing medicine shortages, patients are not receiving the treatment they need, and the transport of patients to treatment centers has been cut."

14 Dec 2012

Gender inequality must be addressed to 'get to zero' in AIDS epidemic

"What does it take to get to zero? While reflecting on the theme of this past World AIDS Day (Getting to zero, Zero new infections, Zero discrimination, Zero deaths), I asked myself this question," Lisa MacDonald, project manager at HealthBridge Foundation of Canada, writes in a Huffington Post Canada opinion piece.

14 Dec 2012

Medivir commences cohort 2 simeprevir and sofosbuvir phase II combination trial in HCV GT1

Medivir AB, announced today the initiation of cohort 2 in the interferon-free phase II trial combining simeprevir with sofosbuvir (GS7977) based on a safety and efficacy planned interim analysis of cohort 1 including prior null responder HCV genotype 1 infected patients without advanced hepatic fibrosis.

13 Dec 2012

Reproductive Health Matters' supplement issue focuses on pregnancy decisions of HIV-positive women

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today publication of Reproductive Health Matters' 2012 supplement issue "Pregnancy decisions of women living with HIV".

13 Dec 2012

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

"Global efforts to reach the 'three zeros' for women and girls -- zero new HIV infections, zero discrimination and zero AIDS-related deaths -- are gaining momentum," Michelle Bachelet, executive director of U.N. Women, Michel Sidibe, executive director of UNAIDS, and Jennifer Gatsi Mallet, executive director of the Namibia Women's Health Network, write in an Inter Press Service opinion piece.

13 Dec 2012

Patients with multiple sclerosis have low levels of Egr2/3 protein in T lymphocytes

Researchers from Queen Mary, University of London have discovered that two proteins which are believed to play a key role in controlling the body's immune response are found in lower levels in T lymphocytes from patients with multiple sclerosis (MS).

13 Dec 2012

BBC News examines HIV microbicide research

BBC News examines ongoing efforts to develop a female-controlled microbicide to prevent HIV infection. But so far, "efforts ... have presented a great deal of frustration in the fight against this global epidemic," the news service writes, detailing the history of some failed experiments.

12 Dec 2012

AstraZeneca, Case Western Reserve initiate AZD5847 Phase 2a trial in TB

Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis (TB), including patients with HIV co-infection.

12 Dec 2012

Uganda's proposed anti-homosexuality legislation would inhibit health care access

The Center for Global Health Policy's "Science Speaks" blog examines the potential impacts of a proposed anti-homosexuality bill in Uganda, writing that the bill "would stand as an obstacle to both access to health care and to the ability of health care providers to even offer services," making prevention of "the bill's passage a matter of life and death, as well as of rights and dignity."

12 Dec 2012

Drugs for Neglected Diseases receives UNITAID grant for paediatric HIV programme

The Drugs for Neglected Diseases initiative welcomes the announcement by UNITAID to grant up to USD 17.3 million to the organization for its paediatric HIV programme.

12 Dec 2012

Clinical trial to examine AstraZeneca experimental drug against pulmonary tuberculosis

A clinical trial will examine an investigational drug's early bacteria-killing activity in patients newly diagnosed with drug-sensitive pulmonary tuberculosis.

12 Dec 2012

HIV 1 News and Research

International community must keep fighting to end mother-to-child HIV transmission

IRMA, Population Council and MTN release Rectal Revolution video project

Increased life expectancy not benefitting everybody equally: U of T

PlusNews reviews AVAC priorities for 2013 HIV prevention agenda

Though progress made, global burden of HIV/AIDS requires greater, 'better' response

Examining developing country contributions to AIDS response

WHO releases new guidelines for interventions aimed at protecting sex workers from HIV

Study suggests that existing HIV drug could be a potential therapy for Staph infections

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

IRIN examines HIV/AIDS response in Guinea-Bissau

Gender inequality must be addressed to 'get to zero' in AIDS epidemic

Medivir commences cohort 2 simeprevir and sofosbuvir phase II combination trial in HCV GT1

Reproductive Health Matters' supplement issue focuses on pregnancy decisions of HIV-positive women

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

Patients with multiple sclerosis have low levels of Egr2/3 protein in T lymphocytes

BBC News examines HIV microbicide research

AstraZeneca, Case Western Reserve initiate AZD5847 Phase 2a trial in TB

Uganda's proposed anti-homosexuality legislation would inhibit health care access

Drugs for Neglected Diseases receives UNITAID grant for paediatric HIV programme

Clinical trial to examine AstraZeneca experimental drug against pulmonary tuberculosis

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News